2364 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with advanced gastric or gastroesophageal junction cancer: A phase Ib trial
Year: 2015
Type: article
Source: European Journal of Cancer
Authors: H.C. Chung, H.T. Arkenau, L. Wyrwicz, D.Y. Oh, K.W. Lee, J.R. Infante, K. Chin, A. Von Heydebreck, Y.K. Kang, H. Safran
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2513611853
